VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CLYM
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CLYMClimb Bio, Inc.
$13.42$915M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCLYMQuarterly Financials

Climb Bio, Inc. (CLYM) Quarterly Financials

120+ quarters historyFree accessUpdated daily

Climb Bio, Inc. (CLYM) quarterly income statement — complete revenue, gross profit & net income history

CLYM Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Sales/Revenue00000000000000000000
Revenue Growth %--------------------
Cost of Goods Sold38K30K038K0000000000000000
COGS % of Revenue--------------------
Gross Profit-38K-30K0-38K0000000000000000
Gross Margin %--------------------
Gross Profit Growth %--------------------
Operating Expenses15.17M19.27M14.89M10.64M23.02M10.91M11.73M56.37M3M5.12M5M6.71M23.44M9.55M8.75M13.7M13.13M10.7M9.38M8.71M
OpEx % of Revenue--------------------
Selling, General & Admin5.84M5.53M5.82M4.1M5.69M4.95M5.49M3.67M1.91M2M2.13M3.03M17.72M4.63M4.49M4.93M4.87M3.82M3.39M2.91M
SG&A % of Revenue--------------------
Research & Development9.34M13.74M9.07M6.58M17.33M5.96M6.24M52.7M1.09M3.13M2.88M3.69M5.72M4.93M4.26M8.77M8.26M6.88M5.99M5.79M
R&D % of Revenue--------------------
Other Operating Expenses000-38K0000000000000000
Operating Income-15.21M-19.3M-14.89M-10.68M-23.02M-10.91M-11.73M-56.37M-3M-5.12M-5M-6.71M-23.44M-9.55M-8.75M-13.7M-13.13M-10.7M-9.38M-8.71M
Operating Margin %--------------------
Operating Income Growth %33.92%-76.85%-26.93%81.06%-665.99%-113.02%-134.59%-739.62%87.18%46.39%42.83%51%-78.48%10.74%6.77%-57.36%-90.9%29.15%--
EBITDA-15.17M-19.27M-14.86M-10.64M-23.02M-10.91M-11.73M-56.37M-3M-5.12M-5M-6.71M-23.44M-9.55M-8.75M-13.7M-13.13M-10.7M-9.38M-8.71M
EBITDA Margin %--------------------
EBITDA Growth %34.08%-76.57%-26.69%81.13%-665.99%-113.02%-134.59%-739.62%87.18%46.39%42.83%51%-78.48%10.74%6.77%-57.36%-90.9%-79.91%--
D&A (Non-Cash Add-back)38K30K29K38K0000000000000000
EBIT-15.21M-19.3M-12.89M-8.67M-23.02M-10.91M-11.73M-56.37M-3M-5.12M-5M-6.71M-23.44M-9.55M-8.75M-13.7M-13.13M-10.7M-9.38M-8.71M
Net Interest Income01.83M02.17M2.29M2.52M001.34M1.35M1.26M0900K0383K00000
Interest Income01.83M02.17M2.29M2.52M001.34M1.35M1.26M0900K0383K00000
Interest Expense00000000000000000000
Other Income/Expense1.49M1.78M2M2.01M2.24M2.5M2.84M1.48M1.31M1.48M1.03M1.49M1.15M1.79M-934K-895K-72K158K-232K-12K
Pretax Income-13.72M-17.52M-12.89M-8.67M-20.78M-8.42M-8.89M-54.89M-1.7M-3.64M-3.97M-5.22M-22.29M-7.76M-9.68M-14.6M-13.2M-10.54M-9.62M-8.72M
Pretax Margin %--------------------
Income Tax00000000000000000000
Effective Tax Rate %0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%0%
Net Income-13.72M-17.52M-12.89M-8.67M-20.78M-8.42M-8.89M-54.89M-1.7M-3.64M-3.97M-5.22M-22.29M-7.76M-9.68M-14.6M-13.2M-10.54M-9.62M-8.72M
Net Margin %--------------------
Net Income Growth %33.97%-108.13%-44.89%84.21%-1124.57%-131.15%-124.17%-951.51%92.39%53.09%59.02%64.24%-68.81%26.39%-0.7%-67.4%29.01%29.05%--
Net Income (Continuing)-13.72M-17.52M-12.89M-8.67M-20.78M-8.42M-8.89M-54.89M-1.7M-3.64M-3.97M-5.22M-22.29M-7.76M-9.68M-14.6M-13.2M-10.54M-9.62M-8.72M
Discontinued Operations00000000000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.20-0.26-0.19-0.13-0.31-0.13-0.13-1.81-0.06-0.13-0.15-0.19-0.84-0.29-0.37-0.56-0.50-0.40-0.70-0.46
EPS Growth %35.48%-100%-46.15%92.82%-404.89%0%13.33%-852.63%92.69%55.17%59.46%66.07%-68%27.5%47.14%-21.74%70.41%68.5%--
EPS (Basic)-0.20-0.26-0.19-0.13-0.31-0.13-0.13-1.81-0.06-0.13-0.15-0.19-0.84-0.29-0.37-0.56-0.50-0.40-0.70-0.46
Diluted Shares Outstanding68.21M67.37M68M67.59M67.46M64.74M67.01M30.35M27.64M27.31M27.07M26.84M26.54M26.37M26.34M26.3M26.24M26.23M15.59M23.46M
Basic Shares Outstanding68.21M67.37M67.83M67.59M67.46M64.74M67.01M30.35M27.64M27.31M27.07M26.84M26.54M26.37M26.34M26.3M26.24M26.23M15.59M23.46M
Dividend Payout Ratio--------------------